Not applicableStudy completedNCT01232842What this trial is testingBiomarker Study in Tissue Samples From Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 20
Early research (Phase 1)Looking for participantsNCT06484062What this trial is testingTesting the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromesWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeMyelodysplastic Syndrome/Acute Myeloid Leukemia+6 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00750659What this trial is testingNilotinib Pre and Post Allogeneic Stem Cell TransplantationWho this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation Sheba Medical Center 24
Large-scale testing (Phase 3)UnknownNCT00651261What this trial is testingDaunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 717
Very early researchWithdrawnNCT03291353What this trial is testingPhase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid LeukemiaWho this might be right forRefractory Acute Myeloid Leukemia Michael Boyiadzis
Early research (Phase 1)Study completedNCT02914977What this trial is testingLow-Dose Daunorubicin in Relapsed/Refractory Acute LeukemiaWho this might be right forAcute Lymphocytic LeukemiaAcute Myeloid Leukemia Tara Lin 18
Not applicableEnded earlyNCT02145039What this trial is testingReduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic DiseasesWho this might be right forAcute LeukemiasBurkitt's LymphomaChronic Myelogenous Leukemia Masonic Cancer Center, University of Minnesota 2
Testing effectiveness (Phase 2)Looking for participantsNCT05211570What this trial is testingAB8939 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in RelapseMyelodysplastic Syndrome Acute Myeloid Leukemia AB Science 78
Testing effectiveness (Phase 2)Study completedNCT00795769What this trial is testingOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more Fred Hutchinson Cancer Center 49
Large-scale testing (Phase 3)Looking for participantsNCT06083129What this trial is testingPhase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated DonorWho this might be right forGVHD Assistance Publique - Hôpitaux de Paris 324
Large-scale testing (Phase 3)Study completedNCT01191957What this trial is testingBusulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AMLWho this might be right forAcute Myeloid Leukemia (AML) Gruppo Italiano Trapianto di Midollo Osseo 252
Not applicableStudy completedNCT01498302What this trial is testingComparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 10
Testing effectiveness (Phase 2)Study completedNCT00427557What this trial is testingCellular Therapy With Cord Blood CellsWho this might be right forMultiple MyelomaLeukemiaLymphoma M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Ended earlyNCT01159067What this trial is testingDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadWho this might be right forIron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more City of Hope Medical Center 1
Early research (Phase 1)Ended earlyNCT05609942What this trial is testingStudy of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic MalignanciesWho this might be right forAdvanced Systemic Mastocytosis Blueprint Medicines Corporation 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05565105What this trial is testingCD34+ Transplants for Leukemia and LymphomaWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute Guenther Koehne 100
Early research (Phase 1)Ended earlyNCT00101231What this trial is testingFlavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more National Cancer Institute (NCI) 88
Early research (Phase 1)Active Not RecruitingNCT05146739What this trial is testingHighest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell MembraneWho this might be right forAcute Myeloid Leukemia Post Cytotoxic TherapyMyelodysplastic Syndrome Post Cytotoxic TherapyMyeloid Leukemia Associated With Down Syndrome+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00516828What this trial is testingSorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes NCIC Clinical Trials Group 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04763928What this trial is testingTrial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and VenetoclaxWho this might be right forAcute Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 101